TriumphJunheng Appears at the 86th API China Industry Summit

       On May 26-28, the 86th China International Pharmaceutical Raw Materials/Intermediates/Packaging/Equipment Trading Fair (API China&PHARMEX&SINOPHEX, abbreviated as "API China"), hosted by Reed Sinopharm, was grandly held at the China Import and Export Fair (Guangzhou).

            TriumphJunheng has set up an independent booth in API China for the first time, in order to fully showcase the development achievements and new style of the enterprise. The exhibition focuses on showcasing medicinal neutral borosilicate glass tubes with diameters of 10.85mm and 16mm. These two specifications of products can be used for processing pre filled syringes and penicillin bottles for vaccines, attracting much attention.

Triumph Junheng booth and exhibitors

        During the exhibition period of Kaisheng Junheng booth and exhibitors, Kaisheng Junheng received leading and well-known pharmaceutical companies in the pharmaceutical glass packaging industry, and industry peers and customers fully recognized the product quality. Zhang Jianping, the director and deputy general manager of Capvision Junheng, communicated with the heads of enterprises on the production status, quality improvement, new product development and other aspects, and combined with the emergency needs of the COVID-19 prevention and control, discussed the direction of the drug packaging materials industry and the pharmaceutical industry to ensure the stability of the supply chain of the vaccine industry chain, laying a good foundation for the subsequent more efficient and mutually beneficial cooperation model.

The booth is constantly crowded with visitors, and the negotiation area is fully booked

        TriumphJunheng is a subsidiary of China Building Materials Kaisheng Technology Group. It is the fifth high-tech enterprise in the world and the only one in China to achieve stable mass production of high-quality medicinal neutral borosilicate glass tubes using the "full oxygen combustion+electric assisted melting" melting process and Danafila tube process. It has the first mover advantage in conducting research and development of medicinal neutral borosilicate glass technology and a deep technical accumulation. From 2017 to 2020, the company continued to carry out key core technology research and development, constructed a systematic process parameter system, and achieved international advanced product quality, promoting the solid chain reinforcement and strengthening of China's neutral borosilicate glass industry.

        API China is an industry event that covers the entire pharmaceutical industry chain and lifecycle. It is also a centralized display platform for new trends, technologies, concepts, and models in the pharmaceutical industry, providing valuable opportunities for industry professionals to engage in in-depth communication and cooperation. At this exhibition, Kaisheng Junheng demonstrated to the pharmaceutical industry a good corporate image and advanced technological level supported by the strength of central enterprises, while also mastering the latest industry trends and market demands, providing valuable reference for the company to carry out technological upgrading, industrial layout, and market development.   This exhibition is supported by units such as China National Pharmaceutical Group, China Chemical Pharmaceutical Industry Association, and China Pharmaceutical Packaging Association. The exhibition covers an area of 70000 square meters and has four professional exhibition areas, with over 1200 enterprises participating.